z-logo
open-access-imgOpen Access
Prophylactic Oral Dextrose Gel and Neurosensory Impairment at 2-Year Follow-up of Participants in the hPOD Randomized Trial
Author(s) -
Taygen Edwards,
Jane M. Alsweiler,
Caroline A Crowther,
Richard Edlin,
Greg Gamble,
Joanne E Hegarty,
Luling Lin,
Christopher J. D. McKinlay,
Jenny Rogers,
Benjamin Thompson,
Trecia A. Wouldes,
Jane E. Harding
Publication year - 2022
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2022.2363
Subject(s) - medicine , randomized controlled trial , placebo , hypoglycemia , pediatrics , relative risk , anesthesia , surgery , confidence interval , insulin , alternative medicine , pathology
Prophylactic oral dextrose gel reduces neonatal hypoglycemia, but later benefits or harms remain unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom